tradmap

IMDX Insight Molecular Diagnostics Inc.

$4.14 +2.99%

Updated

Healthcare · In Vitro & In Vivo Diagnostic Substances

Insight Molecular Diagnostics Inc. (IMDX) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $135 million. Shares last traded at $4.14, 51.3% below their 52-week high. Over the past year the stock is up 62.4%. Revenue grew 115.6% year over year.

Market Cap
$135M
Shares Out
32.7M
EPS (TTM)
$-2.04
P/E Ratio
P/S Ratio
33.41
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$8.49
52-Week Low
$2.40
Volume
12,559
Avg Vol (3m)
9,865.825

Performance

1W
-3.94%
1M
-17.53%
3M
-37.18%
6M
-24.59%
YTD
-41.44%
1Y
+62.35%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
43.49
SMA (50)
$4.72
SMA (200)
$5.27
Price vs SMA50
-12.36%
Price vs SMA200
-21.44%
ATR (14)
$0.26

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$4M
Net Income
$-49M
Gross Margin
19.9%
Operating Margin
Net Margin
Return on Equity
231.7%
Return on Assets
-167.6%
Current Ratio
2.00
Debt / Equity
-0.09
Revenue Growth (YoY)
+115.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.44 2026-08-10
Q1 2026 $-0.12 2026-05-13
FY 2025 $-1.65 2026-03-26
Q3 2025 $-0.91 2025-11-10
Q2 2026 $-0.57 2026-08-10
Q1 2026 $-0.26 2026-05-13

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

IMDX vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap. Updated

P/S vs peers
33.41 / 4.24 med
+689% premium
1–14 of 14
IDXXIdexx Laboratories$41.7B36.589.1625.0%-1.81%
LNTHLantheus Holdings, Inc.$6.6B23.944.2417.7%+0.17%
CLDXCelldex Therapeutics, Inc.$3.1B-10.282000.34-0.32%
NEOGNeogen Corp$2.5B-322.002.92-0.9%-1.36%
NTLAIntellia Therapeutics, Inc.$1.8B-4.44-0.63%
QDELQuidelortho Corp$955M-0.910.36-39.2%-0.11%
ACHVAchieve Life Sciences, Inc.$855M-7.49-2.18%
TKNOAlpha Teknova, Inc.$388M-23.128.87-38.4%-2.83%
MYGNMyriad Genetics Inc$309M-2.740.38-14.0%-0.31%
IMDXInsight Molecular Diagnostics Inc.$135M-2.7433.41+2.99%
ICCCIMMUCELL CORP /DE/$90M114.192.932.6%-0.35%
QCLSQ/C TECHNOLOGIES, INC.$15M-0.939.79-1.57%
BMRABIOMERICA INC$10M-2.732.31-84.8%+2.51%
CDIOCardio Diagnostics Holdings, Inc.$5M-0.84374.80-1.08%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.